A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleA Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsTiffany M Cortes